4DMedical (FRA:MQ7) Net Interest Margin (Bank Only) %


FRA:MQ7 4DMedical Ltd FRA:MQ7
37 GF Score
Price €2.30
GF Value €0.83
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is 4DMedical Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:MQ7
37GF Score
4DMedical Ltd FRA:MQ7
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is 4DMedical (FRA:MQ7) Overvalued in 2026?

Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued. The current stock price of €2.30 is trading 177.1% above its estimated GF Value™ of €0.83. GuruFocus considers 4DMedical to be Significantly Overvalued.

Key valuation signals for FRA:MQ7:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €0.83 vs. price of €2.30 (177.1% above fair value)
  • GF Score™: 37/100 with 2 warning signs

No single metric tells the full story. See the FRA:MQ7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

4DMedical Business Description

Other Exchanges FDMDF:USA4DX:Australia
Address 700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
37GF Score

Get the complete analysis for FRA:MQ7

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.30
Price
€0.83
GF Value